Jiangsu Hengrui reported CNY7.27B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Sh Fosun Pharma CNY 6.69B 1.9B Dec/2025
Sh Pharmaceutical CNY 7.45B 223.01M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Wuxi Apptec CNY 6.27B 68.16M Mar/2026
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026